Serina Therapeutics awarded patent for its core polymer drug delivery technology

News Outlet:

HUNTSVILLE, Ala., May 20, 2011 /PRNewswire/ — Serina Therapeutics, Inc., a pharmaceutical research and development company, announced that the company was awarded a patent from the United States Patent and Trademark Office covering its polymer technology. The patent entitled "Polyoxazoline and compositions comprising the same" (U.S. Patent No. 7,943,141) covers the synthesis and composition of polyoxazolines for the delivery of different drug molecules.

The patent represents years of groundbreaking research in the development of safe polyoxazoline polymers for drug delivery. It is the first of many patents that Serina has applied for. "This patent award validates our invention and design of a novel drug delivery platform and allows Serina the opportunity to advance some of its proprietary ideas towards full development and eventually commercialization," said Dr. Michael D. Bentley, Chief Scientific Officer and cofounder of the company. "We are now in a position to build a strong pipeline of polymer therapeutic molecules."